since in patients frequently treated with concentrates the prevalence of htlv iii antibodies was also higher , it was not possible to draw any conclusions whether the observed immunologic alterations are due to the htlv iii infection alone or are also induced by the frequent administration of coagulation factor concentrates .
C0019683
htlv iii
C0019693
htlv iii infection